Compare SOPH & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOPH | SABA |
|---|---|---|
| Founded | 2011 | 1988 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.7M | 225.6M |
| IPO Year | 2021 | 1994 |
| Metric | SOPH | SABA |
|---|---|---|
| Price | $4.70 | $8.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 100.3K | 98.5K |
| Earning Date | 03-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.91% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $23.09 | N/A |
| Revenue Next Year | $19.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.58 | $7.72 |
| 52 Week High | $5.70 | $9.46 |
| Indicator | SOPH | SABA |
|---|---|---|
| Relative Strength Index (RSI) | 44.60 | 49.84 |
| Support Level | $4.54 | $7.97 |
| Resistance Level | $4.86 | $8.24 |
| Average True Range (ATR) | 0.27 | 0.09 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 24.26 | 59.26 |
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.